A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer

NCT02399943 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
KRAS Wildtype
NRAS Wildtype
BRAF Wildtype

Interventions

DRUG: Trametinib
DRUG: Panitumumab

Sponsor

University Health Network, Toronto